Vertex Pharmaceuticals and Mammoth Biosciences today announced a new partnership to develop in vivo gene-editing therapies for two genetic diseases using Mammoth’s next-generation CRISPR systems.
Vertex Pharmaceuticals and Mammoth Biosciences today announced a new partnership to develop in vivo gene-editing therapies for two genetic diseases using Mammoth’s next-generation CRISPR systems.
Copyright © 2023 Pacific 8 Ventures